Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess procedural safety and glycemic indices at 6 months in a first-in-human study of duodenal mucosal resurfacing (DMR), a novel, minimally invasive, upper endoscopic procedure involving hydrothermal ablation of the duodenal mucosa, in patients with type 2 diabetes and HbA1c ≥7.5% (58 mmol/mol) on one or more oral antidiabetic agents. RESEARCH DESIGN AND METHODS: Using novel balloon catheters, DMR was conducted on varying lengths of duodenum in anesthetized patients at a single medical center. RESULTS: A total of 39 patients with type 2 diabetes (screening HbA1c 9.5% [80 mmol/mol]; BMI 31 kg/m2) were treated and included in the interim efficacy analysis: 28 had a long duodenal segment ablated (LS; ∼9.3 cm treated) and 11 had a short segment ablated (SS; ∼3.4 cm treated). Overall, DMR was well tolerated with minimal gastrointestinal symptoms postprocedure. Three patients experienced duodenal stenosis treated successfully by balloon dilation. HbA1c was reduced by 1.2% at 6 months in the full cohort (P < 0.001). More potent glycemic effects were observed among the LS cohort, who experienced a 2.5% reduction in mean HbA1c at 3 months postprocedure vs. 1.2% in the SS group (P < 0.05) and a 1.4% reduction at 6 months vs. 0.7% in the SS group (P = 0.3). This occurred despite net medication reductions in the LS cohort between 0 and 6 months. Among LS patients with a screening HbA1c of 7.5–10% (58–86 mmol/mol) and on stable antidiabetic medications postprocedure, HbA1c was reduced by 1.8% at 6 months (P < 0.01). CONCLUSIONS: Single-procedure DMR elicits a clinically significant improvement in hyperglycemia in patients with type 2 diabetes in the short-term, with acceptable safety and tolerability. Long-term safety, efficacy, and durability and possible mechanisms of action require further investigation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The intragastric balloon and transpyloric shuttle trials included some persons with T2D, but numbers were inadequate to assess safety and efficacy in those with T2D.787–789”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [787]
In the citing paper
“Some endoscopic and orally delivered devices have been approved by the FDA for treatment of obesity, including hydrogel capsules,786 intragastric balloon systems,787–788 a transpyloric shuttle that blocks gastric emptying,789 and gastric aspiration therapy that evacuates partial gastric contents following meals via a variation of a percutaneous endoscopic gastrostomy tube.790”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [787]
In the citing paper
“While weight loss following DMR is modest (~2.5 kg at six months), significant metabolic benefits have been reported.”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [92]
In the citing paper
“Improvements in glycemic control, including a 1.2% reduction in HbA1c at six months, have been observed, particularly following long-segment ablation [92].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [92]
Citations
Cites
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066 · cited 1×
“Despite a wide choice of pharmacological interventions, many patients do not achieve adequate control of hyperglycemia (1).”
BackgroundRubino, F., Nathan, D. M., Eckel, R. H., Schauer, P. R., Alberti, K. G. M. M., Zimmet, P. Z., Del Prato, S., Ji, L., Sadikot, S. M., Herman, W. H., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0236 · Cited by 1,008
Self-citationRubino, F., Forgione, A., Cummings, D. E., Vix, M., Gnuli, D., Mingrone, G., Castagneto, M., & Marescaux, J. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000224726.61448.1b · Cited by 928
Self-citationRubino, F., & Marescaux, J. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000102989.54824.fc · Cited by 617
Self-citationHuman duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP
Theodorakis, M. J., Carlson, O., Michopoulos, S., Doyle, M. E., Juhaszova, M., Petraki, K., & Egan, J. M. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00326.2004 · Cited by 396 · cited 1×
“Duodenal biopsy from humans with diabetes also shows hypertrophy, thickening, and an overgrowth of entero-endocrine cell types (22).”
BackgroundLaferrère, B., Reilly, D., Arias, S., Swerdlow, N., Gorroochurn, P., Bawa, B., Bose, M., Teixeira, J., Stevens, R. D., Wenner, B. R., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002043 · Cited by 384
Jacobsen, S. H., Olesen, S. C., Dirksen, C., Jørgensen, N. B., Bojsen-Møller, K. N., Kielgast, U., Worm, D., Almdal, T., Naver, L. S., Hvolris, L. E., et al. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0621-4 · Cited by 342
Jørgensen, N. B., Jacobsen, S. H., Dirksen, C., Bojsen-Møller, K. N., Naver, L., Hvolris, L., Clausen, T. R., Wulff, B. S., Worm, D., Lindqvist Hansen, D., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00073.2012 · Cited by 313
Bojsen-Møller, K. N., Dirksen, C., Jørgensen, N. B., Jacobsen, S. H., Serup, A. K., Albers, P. H., Hansen, D. L., Worm, D., Naver, L., Kristiansen, V. B., et al. (2014) · Diabetes · doi:10.2337/db13-1307 · Cited by 254
Breen, D. M., Rasmussen, B. A., Kokorovic, A., Wang, R., Cheung, G. W. C., & Lam, T. K. T. (2012) · Nature Medicine · doi:10.1038/nm.2745 · Cited by 209 · cited 1×
“This suggests a potential effect on hepatic glucose production, possibly through an insulin-sensitizing mechanism, in line with previous observations in duodenal-jejunal bypass (17) and Roux-en-Y gastric bypass surgery (18–20).”
Result
Cited by
Items 101–200 of 219
Duodenal mucosal resurfacing with photodynamic therapy using methylene blue in a mouse model
Yang, S. M., Myeong, S., Yun, S. K., Kwak, M. H., Cho, Y. K., Choi, M., & Park, J. M. (2023) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2023.103733 · Cited by 8
Minireview: Current status of endoscopic duodenal mucosal resurfacing
Condello, G., & Chen, C.-Y. (2020) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2020.09.001 · Cited by 7
Endobariatrics and Metabolic Endoscopy: Can We Solve the Obesity Epidemic with Our Scope?
Farha, J., Abbarh, S., Haq, Z., Itani, M. I., Oberbach, A., Kumbhari, V., & Badurdeen, D. (2020) · Current Gastroenterology Reports · doi:10.1007/s11894-020-00798-8 · Cited by 7
GIE Editorial Board Top 10: advances in GI endoscopy in 2021
Qayed, E. S., Chua, T. Y., Mulki, R., Yang, D. J., Jamidar, P. A., Singh, A., Leung, F. W., Yu, J. X., & Lightdale, J. R. (2022) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2022.08.004 · Cited by 7
Metabolic and Bariatric Endoscopy: A Mini-Review
Norton, B. C., Telese, A., Papaefthymiou, A., Aslam, N., Makaronidis, J., Murray, C. D., & Haidry, R. J. (2023) · Life · doi:10.3390/life13091905 · Cited by 7
Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes
Bailey, C. J., & Flatt, P. R. (2024) · Peptides · doi:10.1016/j.peptides.2024.171168 · Cited by 6
Duodenal mucosa resurfacing: the endoscopic silver bullet against metabolic disorders?
Lonardo, A., & Singal, A. K. (2025) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2024.130 · Cited by 6
Nuevas tecnologías y avances en terapias para la pérdida de peso
Zerrweck, C., & Espinosa, O. (2020) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2020.05.007 · Cited by 7
Duodenal L cell density correlates with features of metabolic syndrome and plasma metabolites
van Baar, A. C. G., Prodan, A., Wahlgren, C. D., Poulsen, S. S., Knop, F. K., Groen, A. K., Bergman, J. J. G. H. M., Nieuwdorp, M., & Levin, E. (2018) · Endocrine Connections · doi:10.1530/ec-18-0094 · Cited by 6
Small Bowel Endoscopic Bariatric Therapies
Gong, E. J., & Kim, D. H. (2018) · Clinical Endoscopy · doi:10.5946/ce.2018.153 · Cited by 8
“The first human study of DMR with varying lengths showed favorable short-term outcomes with acceptable tolerability.(35) Both long- (≥9 cm) and short-segment DMR (<6 cm) resulted in a significant improvement in the glycemic indexes of patients with T2DM over 6 months of follow-up.”
BackgroundSmall intestine‐targeted endoscopic bariatrics: Current status and future perspectives
Ren, M., & Ji, F. (2023) · Digestive Endoscopy · doi:10.1111/den.14575 · Cited by 5
Endoscopic Interventions in the Treatment of Obesity and Diabetes
Ruban, A., Uthayakumar, A. K., Ashrafian, H., & TEARE, J. P. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5117-1 · Cited by 5
Endoscopy in Obesity Management: A Comprehensive Guide
(2017) · Springer eBooks · doi:10.1007/978-3-319-63528-6 · Cited by 5
Current Endoscopic/Laparoscopic Bariatric Procedures
Mathus-Vliegen, E. M. H., & Dargent, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-90074-2_2 · Cited by 8
Evolving procedural options for the treatment of obesity
Tatarian, T., Rona, K. A., Shin, D. H., Chen, D. G., DuCoin, C. G., Moore, R., Brunaldi, V., Neto, M. G., Ardila-Gatas, J., Docimo, S., et al. (2020) · Current Problems in Surgery · doi:10.1016/j.cpsurg.2020.100742 · Cited by 5
Self-citationBoškoski, I., Orlandini, B., Gallo, C., Bove, V., Pontecorvi, V., Perri, V., & Costamagna, G. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1757429 · Cited by 5
“Insulin-dependent type 1 diabetes (T1D), gastrointestinal anatomical variations, history of gastrointestinal surgery, coagulative dysfunctions needing continuous anticoagulant therapy, pregnancy and severe comorbidities were the main excluding reasons reported [15,20].”
BackgroundMethodInfluentialO'Neal, D. N., Sartoretto, A., Holt, B. A., Dayyeh, B. K. A., Vaughan, R., Cameron, G. R., Chandran, S., Thompson, A. J., McCollister, H. M., Severson, P. A., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70533 · Cited by 5
“17,18 Pulsed electric field (PEF) therapy represents a next-generation, non-thermal approach that induces controlled electroporation of duodenal cells, promoting cellular renewal while preserving tissue architecture.”
Meiring, S., Aydin, Ö., van Baar, A. C. G., van der Vossen, E. W. J., Rampanelli, E., van Grieken, N. C. T., Holleman, F., Nieuwdorp, M., & Bergman, J. J. G. H. M. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08710-4 · Cited by 4
“[17, 18] Exogenous insulin administration was discontinued immediately after the DMR procedure and patients were instructed to adhere to a 2 week post-proce-dural diet after which patients began with self-administration of subcutaneous GLP-1RA, liraglutide (Victoza®, Novo Nordisk A/S).”
InfluentialCarlson, T. L., Colbert, K., Vieira, M., Guerina, F. V., Bryant, C. L. N., Habegger, K. M., Pasricha, P. J., Petersen, J. S., Polomoscanik, S. C., Jozefiak, T. H., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu1326 · Cited by 4
Norton, B. C., Papaefthymiou, A., Telese, A., Simons-Linares, C. R., Vargo, J., Sharma, V. K., & Haidry, R. J. (2025) · Frontline Gastroenterology · doi:10.1136/flgastro-2025-103211 · Cited by 4
“For example, Rajagopalan et al 28 showed that long-segment ablation (≤3 cm vs≥9 cm) led to a non-significant increase in HbA1c reduction (−1.4% vs −0.7%; p=0.3) and evidence from both mice and humans suggests the length of the biliopan-creatic limb following RYGB correlates with the degree of glycaemic improvement.”
InfluentialASGE EndoVators Summit: Defining the role and value of endoscopic therapies in obesity management
Ryou, M. K., McQuaid, K. R., Thompson, C. C., Edmundowicz, S. A., Mergener, K., Dayyeh, B. A., Apovian, C. M., Burke, C. A., Chand, B., Chandraker, A. K., et al. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.08.024 · Cited by 7
Self-citationAktuelle endoskopische Methoden in der Adipositas- und metabolischen Chirurgie
Stroh, C., Will, U., Meyer, F. P., & Manger, T. (2018) · Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie · doi:10.1055/a-0638-8373 · Cited by 4
“Die thermische Ablation der Duodenalschleimhaut erfolgt nach Lifting der Schleimhaut mittels eines Ballons, der mit 87,2 °C heißer Kochsalzlösung gefüllt ist [18,19].”
BackgroundEvolution of Endoscopic Bariatric Devices: From Development to Practice
Goyal, D., Singh, V. K., & Amateau, S. K. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000134 · Cited by 4
Castro, M., & Guerron, A. D. (2020) · Mini-invasive Surgery · doi:10.20517/2574-1225.2020.14 · Cited by 4
“This therapy has shown positive outcomes in management for diabetes [14,28,29] .”
BackgroundNociarova, J., Novák, M., Polak, J., Hrudka, J., Porubský, Š., Koc, M., Rosina, J., Grebenyuk, A. N., Šerý, R., Gürlich, R., et al. (2021) · Journal of Healthcare Engineering · doi:10.1155/2021/9986874 · Cited by 4
Duodenal mucosal resurfacing for nonalcoholic fatty liver disease
Shamseddeen, H., Vuppalanchi, R., & Gromski, M. A. (2022) · Clinical Liver Disease · doi:10.1002/cld.1255 · Cited by 4
Are We Moving in the Right Direction by Altering Gastric Motility for Weight Loss?
Sharaiha, R. Z., & Kumbhari, V. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.009 · Cited by 4
Endoscopic Treatments for Obesity
Egan, A. M., & Vella, A. V. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.02.001 · Cited by 4
Latest Developments and Future Perspectives in the Field Of Obesity
Pérez‐Pevida, B., & Miras, A. D. (2017) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2017.13.01.17 · Cited by 4
Endoscopic duodenal mucosa ablation: the future of diabetes treatment?
Musso, G., Cassader, M., & Gambino, R. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.03.003 · Cited by 3
Endoscopic Weight Loss Options
Bi, D., & Jirapinyo, P. (2025) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2024.11.002 · Cited by 3
Busch, C. B. E., van den Hoek, K., van Baar, A. C. G., Meiring, S., Bouwmeester, T. A., Holleman, F., Nieuwdorp, M., & Bergman, J. J. G. H. M. (2025) · iGIE · doi:10.1016/j.igie.2025.03.012 · Cited by 4
Chablaney, S., & Kumta, N. A. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12878 · Cited by 3
“Serious adverse events included duodenal stenosis in three patients treated successfully with balloon dilation.(55) Further studies are needed to elucidate the long-term safety and efficacy of this procedure.”
BackgroundInfluentialLess Invasive Bariatric/Metabolic Procedures for Weight Reduction and Glucose Control
Park, Y. S., Ahn, S. H., Suh, Y., & Kim, H. (2020) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes20019 · Cited by 3
Park, C. S., Park, H. J., Park, J. H., Lee, J. H., Kee, H. J., Park, J., Jo, J. H., Lee, H. S., Ku, C. R., Park, J. Y., et al. (2024) · APL Bioengineering · doi:10.1063/5.0206328 · Cited by 3
ASGE EndoVators Summit: Defining the role and value of endoscopic therapies in obesity management
Ryou, M. K., McQuaid, K. R., Thompson, C. C., Edmundowicz, S. A., & Mergener, K. (2017) · Metabolism · doi:10.1016/j.metabol.2017.11.013 · Cited by 3
Self-citationCurrent and Future Endoscopic Weight Loss Solutions
Khaitan, L., & Shea, B. J. (2020) · Techniques in vascular and interventional radiology · doi:10.1016/j.tvir.2020.100655 · Cited by 3
Therapeutic Management of Obesity
Bray, G. A. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_17 · Cited by 4
Truong, V. G., Jeong, S. W., Lee, J., Kim, H.-J., Ta, M. D., & Kang, H. W. (2025) · Lasers in Medical Science · doi:10.1007/s10103-025-04571-z · Cited by 3
Ramírez-Mejía, M. M., & Méndez‐Sánchez, N. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i8.108845 · Cited by 2
Small Bowel Target Devices and Techniques
Edmundowicz, S. A. (2017) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2017.01.001 · Cited by 2
Endoscopic Accessories Used for More Advanced Endoluminal Therapeutic Procedures
Chung, H. (2017) · Clinical Endoscopy · doi:10.5946/ce.2017.079 · Cited by 3
“The result of a single center, single-arm, open-label, nonrandomized study of DMR in type 2 diabetes to evaluate six-month safety and efficacy has recently been published.(52) HbA1c was reduced by 1.”
BackgroundEndoscopic Primary Bariatric Procedures
Scerbo, M. H., Felinski, M. M., Bajwa, K. S., Wilson, E. B., & Shah, S. K. (2019) · Springer eBooks · doi:10.1007/978-3-030-27021-6_36 · Cited by 2
Kim, S. H., & Lee, J. K. (2023) · International Journal of Gastrointestinal Intervention · doi:10.18528/ijgii220018 · Cited by 2
Das, S. S., & Mahapatra, S. K. (2024) · Journal of Biomechanical Engineering · doi:10.1115/1.4065058 · Cited by 2
Chiu, H. H. C., & Wang, J. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188241252308 · Cited by 2
Pop, R., Kong, S., Langlois, A., Marchegiani, F., Shlomovitz, E., Légner, A., Bietiger, W., Pinget, M., Beaujeux, R., Mutter, D., et al. (2019) · Surgical Innovation · doi:10.1177/1553350619838098 · Cited by 2
Food intake regulation: Relevance to bariatric and metabolic endoscopic therapies
Izundegui, D. G., Singh, S., & Acosta, A. J. (2020) · Techniques and Innovations in Gastrointestinal Endoscopy · doi:10.1016/j.tige.2020.03.007 · Cited by 3
Novel gastrointestinal procedures
Januszewicz, W., & di Pietro, M. (2019) · Medicine · doi:10.1016/j.mpmed.2019.04.009 · Cited by 3
Johnston, M. P., Buchanan, R. M., Patel, J., & Tehami, N. (2020) · Gut · doi:10.1136/gutjnl-2020-320900 · Cited by 2
The changing face of hepatology
Berenguer, M. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.11.003 · Cited by 1
Clinical efficacy and mechanism of action of medical devices for obesity and type 2 diabetes
Ansari, S., & Miras, A. D. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100324 · Cited by 1
Small Bowel Therapies for Metabolic Disease and Obesity
Boškoski, I., Gualtieri, L., & Matteo, M. V. (2024) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2024.06.002 · Cited by 1
Dawit, L., Quon, C. M., Bachu, V. S., Jumo, H., Micalo, L., & Issa, D. (2025) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002291 · Cited by 1
D’Alessio, D. A., & Campbell, J. E. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70894 · Cited by 1
Endoscopic Treatment for Obesity and Weight Management: State of the Art
Jaruvongvanich, V., Storm, A. C., & Dayyeh, B. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-29964-4_42-1 · Cited by 1
Novel gastrointestinal procedures
di Pietro, M. (2015) · Medicine · doi:10.1016/j.mpmed.2015.03.015 · Cited by 1
Endoluminal Small Bowel Procedures for Obesity and Metabolic Diseases
Jirapinyo, P., & Thompson, C. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-63528-6_15 · Cited by 1
Self-citationASGE EndoVators Summit: Defining the Role and Value of Endoscopic Therapies in Obesity Management
ASGE EndoVators Task Force, Ryou, M. K., McQuaid, K. R., Thompson, C. C., Edmundowicz, S. A., & Mergener, K. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2948-3 · Cited by 1
“Additionally, modest weight effects have been shown [62].”
BackgroundSelf-citationEndoscopic Bariatric/Metabolic Surgery
Kazi, D., & Khaitan, L. (2018) · Digestive Disease Interventions · doi:10.1055/s-0038-1675593 · Cited by 1
Emerging Endoscopic Therapies for Weight Loss
Wang, T. J., & Ryou, M. K. (2019) · Springer eBooks · doi:10.1007/978-3-030-21695-5_14 · Cited by 1
New Devices for Endoscopic Treatments in Gastroenterology: A Narrative Review
Furnari, M., Telese, A., Hann, A., Lisotti, A., Boškoski, I., & Eusebi, L. H. (2020) · Current Drug Metabolism · doi:10.2174/1389200221666200722145727 · Cited by 1
New technologies and advances in weight loss therapy
Zerrweck, C., & Espinosa, O. (2020) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2020.05.004 · Cited by 2
Endoscopic Techniques for Obesity and Diabetes
Brunaldi, V., Filho, J. A. F., & Martone, D. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_44 · Cited by 1
Loiola, B. R., Neto, F. S., & Guedes, R. O. D. C. (2021) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2021.106413 · Cited by 1
Training in Bariatric Endoscopy
de Moura, D. T. H., Jirapinyo, P., & Thompson, C. C. (2022) · Wiley eBooks · doi:10.1002/9781119529675.ch23 · Cited by 1
Self-citationWaataja, J. J., Ikramuddin, S., Gal, D., & Billington, C. J. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002713 · Cited by 1
Loiola, B. R., Neto, F. S., & Guedes, R. O. D. C. (2019) · Mecánica Computacional (Asociación Argentina de Mecánica Computacional) · Cited by 1
Dolo, P. R., Yao, L., Shao, Y., Widjaja, J., Li, C., & Zhu, X. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.07.025 · Cited by 1
Index Endoscopic Malabsorptive Procedures in Obesity Treatment: Techniques and Outcomes
Noria, S. F., Mansfield, S. A., & Mikami, D. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-71282-6_22 · Cited by 1
Prabhakar, S. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/849091 · Cited by 1
“Furthermore, duodenal mucosal removal 265 abrogates hyperglycemia [18,19], which provides evidence that bacterial zinc proteinases play a 266 central role in T2DM.”
BackgroundDuodenal endoscopic interventions for obesity and diabetes
Lo, S. K. (2017) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2016.09.024
Interventioneller Ansatz zur Diabetestherapie hat Potenzial
Schlimpert, V. (2017) · Info Diabetologie · doi:10.1007/s15034-017-1060-z
ASGE EndoVators Summit: Defining the Role and Value of Endoscopic Therapies in Obesity Management
Ryou, M. K., McQuaid, K. R., Thompson, C. C., Edmundowic, S., Mergener, K., Ryou, M. K., McQuaid, K. R., McQuaid, K. R., Thompson, C. C., Edmundowicz, S. A., et al. (2017) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-017-3609-5
Self-citationBléro, D. (2017) · Acta Endoscopica · doi:10.1007/s10190-017-0638-1
Role of Endoscopy in the Treatment of Bariatric and Metabolic Disease
Jung, K. U. (2018) · Journal of Metabolic and Bariatric Surgery · doi:10.17476/jmbs.2018.7.1.37
“6개월 추적관찰에서 대상군의 몸무 게는 시술 전과 크게 변화가 없었으나 당화혈색소와 HOMA-IR 은 유의한 호전을 보였으며 간효소치의 감소도 관찰되었다 [91,92].”
Endoscopic Bariatric Therapies
Choi, A. J., & Sharaiha, R. Z. (2018) · Springer eBooks · doi:10.1007/978-3-319-93545-4_26
Mathus-Vliegen, E. M. H., & Dargent, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-90074-2_10
When Surgeons and Endoscopists Are Possible Opponents
Mathus-Vliegen, E. M. H., & Dargent, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-90074-2_11
Metabolic endoscopy, here to stay!
Edmundowicz, S. A. (2019) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2019.06.026
Bariatric Endoscopic Procedures: Malabsorptive Devices and Methods
Broderick, R. C., & Sandler, B. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-23590-1_28
The benefits of metabolic/bariatric surgery on diabetes mellitus
Buchwald, H., & Buchwald, J. N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814831-0.00016-6
Dhruvan, P., Morgenstern, R., Daxini, A., & Steven, L. (2020) · Journal of Clinical Gastroenterology and Treatment · doi:10.23937/2469-584x/1510077
Endoscopic Duodenal Mucosal Resurfacing: A Potential Therapeutic Treatment for Metabolic Disease
Hadefi, A., & Deviere, J. M. E. (2021) · Springer eBooks · doi:10.1007/978-981-15-9247-8_13
Duodenal Resurfacing for Treatment of Type 2 Diabetes
Hadefi, A., & Deviere, J. M. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-29964-4_46-1
Duodenal Resurfacing for Treatment of Type 2 Diabetes
Hadefi, A., & Deviere, J. M. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-56993-8_46
Type 2 diabetes: glycaemic control
FRCP, D. L. M. (2017) · Wiley eBooks · doi:10.1002/9781119052210.ch10
Endoscopic Treatment for Obesity and Weight Management: State of the Art
Jaruvongvanich, V., Storm, A. C., & Dayyeh, B. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-56993-8_42
Endoskopische postoperative Diagnostik und endoskopische bariatrische Eingriffe
Stier, C. K. (2022) · Springer eBooks · doi:10.1007/978-3-662-63705-0_20
(2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1509-6011
“Bei allen Patienten war im Verlauf eine vollständige Heilung der Duodenalschleimhaut feststellbar [6].”
BackgroundEndoscopic Management of Obesity
Dolan, R. D., Jirapinyo, P., & Laster, J. (2022) · Springer eBooks · doi:10.1007/978-3-030-94953-2_15
New Technologies to Treat Obesity and Related Comorbidities
Brunaldi, V., & Neto, M. G. (2023) · Springer eBooks · doi:10.1007/978-3-031-21044-0_39
Neues endoskopisches Verfahren zur Behandlung des Typ-2-Diabetes
Martin, S., & ten Beyna, T. (2023) · Info Diabetologie · doi:10.1007/s15034-023-4516-3
Endoscopic Postoperative Diagnosis and Endoscopic Bariatric Interventions
Stier, C. K. (2023) · Springer eBooks · doi:10.1007/978-3-662-66436-0_20
Endoscopic Bariatric Therapy for Obesity and Metabolic Syndrome
Lee, S. P. (2023) · The Korean Journal of Helicobacter and Upper Gastrointestinal Research · doi:10.7704/kjhugr.2023.0049
Endoscopic Methods in Obesity Treatment
Ergin, A., & Şahan, C. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004427
Sachan, A., & Kushwah, S. (2024) · Indian Journal of Gastroenterology · doi:10.1007/s12664-024-01640-z
What is Duodenal Mucosal Resurfacing?
Cha, B. (2024) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2024.075
Mucosal Resurfacing in the Management of Type II Diabetes
Neto, M. G., McCarty, T. R., Campos, J. M., & de Quadros, L. G. (2024) · Springer eBooks · doi:10.1007/978-3-031-70004-0_37
Metadata
- Authors
- Rajagopalan, H., Cherrington, A. D., Thompson, C. C., Kaplan, L. M., Rubino, F., Mingrone, G., Becerra, P., Rodriguez, P., Vignolo, P., Caplan, J., Rodriguez, L., & Galvao Neto, M. P.
- Affiliations
- Fractyl (United States) (US)
- Vanderbilt University Medical Center (US)
- Brigham and Women's Hospital (US)
- Massachusetts General Hospital (US)
- King's College London (GB)
- Catholic University of Rome, Rome, Italy
- CCO Clinical Center for Diabetes, Obesity and Reflux, Santiago, Chile
- Gastro Obeso Center, São Paulo, Brazil
- Corresponding author
- Rajagopalan, Harith
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-08-12
- Volume
- 39
- Issue
- 12
- Pages
- 2254-2261
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2514895276
- Cited by
- 216
- References
- 35
- Citations by year
- 2026: 9 · 2025: 21 · 2024: 17 · 2023: 14 · 2022: 17 · 2021: 25 · 2020: 34 · 2019: 24 · 2018: 20 · 2017: 32 · 2016: 2
- FWCI
- 26.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Fractyl Laboratories, Inc
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- duodenal mucosal resurfacing, type 2 diabetes, HbA1c reduction, glycemic control, balloon catheter, duodenal stenosis, antidiabetic medication reduction, procedural safety, first-in-human study
- MeSH terms
- Adult, Aged, Blood Glucose, Combined Modality Therapy, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Duodenum, Female, Glycated Hemoglobin, Humans, Hyperglycemia, Hypoglycemic Agents, Intestinal Mucosa, Male, Middle Aged, Pilot Projects, Endoscopy, Gastrointestinal, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.